Fluticasone Furoate/Vilanterol Trifenatate

Product Name :
Fluticasone Furoate/Vilanterol Trifenatate

Search keywords :
Fluticasone furoate

drugId :
null

Target Vo:
Beta-2 adrenergic receptor

Target Vo Short Name :
ADRB2

Moa_Name:
Glucocorticoid receptor agonists

First Approval Country :
United States

First Approval Date Filter:
2013

Origin Company_Name :
Glaxosmithkline Biologicals SA

Active Company_Name :
Glaxo Group Ltd

Active Indication_Name:
Pulmonary Disease, Chronic Obstructive

In Active Indication_Name:
Cardiovascular Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-ATM (S1981) Antibody
Phospho-Chk2 (Thr68) Antibody
NF-KB p105 Antibody (YA700): NF-KB p105 Antibody (YA700) is a non-conjugated and Mouse origined monoclonal antibody about 105 kDa, targeting to NF-KB p105 (5E3). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts